Prostate-specific membrane antigen (PSMA) has transformed how doctors diagnose and treat the disease, offering patients ...

Mogensen, A. W., et al. (2025) The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer Treated with Salvage Radiotherapy: Real-World Data from an ...

Dr. Yonover says a PSMA Pet Scan is relatively new technology that has revolutionized how doctors are diagnosing and treating prostate cancer. It allows doctors to isolate the tumors.

We are using mainly PSMA as a target to image prostate cancer. PSMA is a dimeric type II integral membrane glycoprotein, highly expressed on prostate cancer cells but also on tumor neovasculature. Our ...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's trofolastat, a PSMA-targeting agent for detecting lesions in men with ...

VANCOUVER, British Columbia-- (BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced new data on its PSMA x CD3 T-cell engagers (TCEs), presented as a poster at the American Association for ...